SENDAI, Japan: Periodontitis affects many people and can have serious effects on oral health. In new research originating from Japan, scientists have developed a cell-based regenerative therapy approach. The proposed therapy design promises to address periodontitis without some of the shortcomings and limitations of regenerative therapies to date.
According to the researchers from Tohoku University in Sendai, the therapy will be faster and cheaper. “The use of cell-based therapies is a promising approach to treat human disease. This kind of treatment paradigm is important because commercially available stem cells that represent a cell-based therapy specifically developed to treat periodontal tissue regeneration will reduce time and cost while improving quality assurance,” said lead author Prof. Masahiro Saito, from the Department of Restorative Dentistry at Tohoku University Graduate School of Dentistry.
In a new approach to the treatment of periodontitis, the researchers transplanted stem cells from healthy mini pigs to those who had periodontal defects and, by doing so successfully, overcome the shortcomings that can be associated with autologous stem cell treatments. By using this mini pig periodontal defect model, they demonstrated that allogeneic adipose-derived mesenchymal progenitor stem cells (ADMPCs)—mesenchymal stem cells (MSCs) derived from fat tissue—are safe and effective for the treatment of periodontitis.
“Our study demonstrates that ADMPCs appear to be safe and not triggering an immune response in allogeneic settings, and as such it explores the potential use of allogeneic MSCs for tissue regeneration. The study is a powerful first step towards further development of stem cell-based therapy for the treatment of periodontal disease,” explained Saito.
The study, titled “Periodontal regeneration by allogeneic transplantation of adipose tissue derived multi-lineage progenitor stem cells in vivo”, was published on 29 January 2019 in Scientific Reports. The study was conducted in collaboration with researchers from Osaka University in Osaka and Fujita Health University in Toyoake.
LOS ANGELES, U.S.: Recent studies showing an increase in patients with periodontitis, as well as studies linking it with Alzheimer’s disease, have led to ...
WHANGANUI, New Zealand: Aiming to find a safer, more effective and faster treatment method to reduce the high prevalence of dental caries in children in New...
BETHLEHEM, Pa., US: Aggressive forms of periodontitis associated with Aggregatibacter actinomycetemcomitans are often difficult to treat with traditional ...
SEOUL, South Korea: As periodontitis and halitosis share a microbiological pathogenesis, researchers from the Seoul National University School of Dentistry ...
CHAMPIONSGATE, Fla., U.S.: In the interest of public health, the International Academy of Oral Medicine and Toxicology (IAOMT) has published a new research ...
What do endodontic experts base their decisions on: intuition, experience or CBCT imaging? The following case report on a 10-year-old patient shows that an ...
WASHINGTON, U.S.: Prevention is always the best place to start when talking about dental care; however, many patients would be thrilled to have access to an...
NEW YORK, U.S.: When it comes to endodontic treatment, elimination of the microbial flora from the root canal system is a primary focus. In a free Dental ...
LEIPZIG, Germany: Studies have increasingly given credence to the old adage “Smile and the world smiles with you”, but our instinct for mimicking the ...
TAIPEI, Taiwan: Conventional periodontal therapies, while effective to a degree, often fall short of fully restoring the complex architecture and function ...
Live webinar
Tue. 30 September 2025
8:00 pm EST (New York)
Dr. Elisa Chavez DDS, Dr. Teresa A. Dolan DDS, MPH, Dr. Linda Niessen, Dr. Lisa Simon
Live webinar
Wed. 1 October 2025
1:00 pm EST (New York)
Live webinar
Thu. 2 October 2025
9:00 am EST (New York)
Live webinar
Mon. 6 October 2025
12:30 pm EST (New York)
Live webinar
Tue. 7 October 2025
12:30 pm EST (New York)
Prof. Dr. Falk Schwendicke MDPH
Live webinar
Thu. 9 October 2025
8:00 am EST (New York)
Dr. Priyantha Pang Lee Yek
Live webinar
Fri. 10 October 2025
5:00 am EST (New York)
Prof. Dr. Dr. Florian Stelzle
So when will it be available into clinical trials??
Even with current dentistry treatment approach, ranging from first stage to middle stage is only treatable scope but not for advanced stage aggravation.
So does this scientifical breakthrough take into account such complicated issue??
will this be done in conjunction with surgery?